Health News

(World Journal of Gastroenterology) Troglitazone-suppressed stomach cancer via activation of PPAR-gamma, and stomach cancer was suppressed by apoptosis mediated by PPAR-gamma ligands. After we confirmed the appearance of PPAR-gamma with two types of stomach cancer cells and disposed of ciglitazone and troglitazone, both of which induce PPAR-gamma activation, we were able to identify cell proliferation, confirm the effects of PPAR-gamma suppressors, and clarify any genetic alterations for the growth of stomach cancer cells using cDNA microarrays.

Read more

Filed under: General Health News
Tags: cancer, General Health News, Genetic

Related posts

• UBC researchers discover gene mutation that causes eye cancer (0)
  (University of British Columbia) A University of British Columbia geneticist has discovered a gene mutation that can cause the most common eye cancer -- uveal melanoma.Catherine Van Raamsdonk, an assistant professor of medical genetics in the UBC Faculty of Medicine and a team of researchers, have discovered a genetic mutation in a gene called GNAQ [...]
  
  
• Treatment Delay and Genetics May Affect Breast Cancer Prognosis in Hispanic Women (0)
  Breast cancer could be more aggressive in Hispanic women because of delays in seeking medical care and a higher incidence of triple-negative breast cancer among Hispanic women with a family history of the disease. Medscape Medical News Read more [tags] General Health News [/tags]
  
  
• St. Jude identifies genomic causes of a certain type of leukemia relapse (0)
  Scientists at St. Jude Children's Research Hospital have identified distinctive genetic changes in the cancer cells of children with acute lymphoblastic leukemia (ALL) that cause relapse. Read more [tags] General Health News [/tags]
  
  
• Scientists sequence genome of a cancer patient (0)
  For the first time, scientists have decoded the complete DNA of a cancer patient and traced her disease - acute myelogenous leukemia - to its genetic roots. Read more [tags] General Health News [/tags]
  
  
• SABCS: Women at Genetic Risk of Breast Cancer Don’t Want to Hear It by Phone (0)
  SAN ANTONIO (MedPage Today) -- Many women tested for genetic breast cancer risk may say they're willing to get the results over the phone, but the experience may not be as palatable as expected, researchers found. Read more [tags] General Health News [/tags]